ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
2018年02月21日 09時00分
Source:
Eisai
エーザイ、「健康経営優良法人2018~ホワイト500~」に認定
東京, 2018年02月21日 - (JCN Newswire) - エーザイ株式会社(本社:東京都、代表執行役 CEO:内藤晴夫)は、このたび、経済産業省が、医療団体、経済団体や自治体のリーダーから構成される日本健康会議と連携して認定制度を運営する「健康経営優良法人(大規模法人部門)2018 ~ホワイト 500~」に認定されましたのでお知らせします。
「健康経営優良法人制度」とは、地域の健康課題に即した取り組みや日本健康会議が進める健康増進の取り組みをもとに、特に優良な健康経営を実践している大企業や中小企業等の法人を顕彰する制度です。「健康経営優良法人(大規模法人部門)」の認定においては、「経営理念(経営者の自覚)」、「組織体制」、「制度・施策実行」、「評価・改善」、「法令順守・リスクマネジメント」の 5つが基準として定められています。第 2 回目となる今回は、「大規模法人部門(ホワイト 500)」として 541 法人、「中小規模法人部門」として 775 法人が認定されました。
当社は、患者様とそのご家族の喜怒哀楽を第一義に考え、そのベネフィット向上に貢献し、世界のヘルスケアの多様なニーズを充足することを企業理念と定めています。企業理念の実現のためには、会社の主要なステークホルダーズである社員の健康の維持および増進は重要な要素の一つであり、今後も健康経営の実践に向けた取り組みを推進してまいります。
本リリースの詳細は下記をご参照ください。
http://www.eisai.co.jp/news/news201814.html
概要:エーザイ株式会社
詳細は www.eisai.co.jp をご覧ください。
Source: Eisai
セクター: バイオテック
Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Mitsubishi Shipbuilding Receives Order for the MAmmoSS(R) Ammonia Fuel Handling System
Jun 27, 2026 13:16 JST
MHI Study Results Indicate Potential Cost Reductions in the Decarbonization Value Chain Using Green Hydrogen and Ammonia Produced in India
Jun 27, 2026 13:00 JST
Foxconn and Sharp Signs Memorandum of Understanding for Strategic Collaboration in New Business Areas
Jun 27, 2026 12:44 JST
DENSO Group Formulates New Environmental Policy "Eco Vision 2035"
Jun 27, 2026 11:58 JST
JCB and PNB Launch New Platinum Credit Card, Empowering Consumers with Greater Value and Lifestyle Benefits
Jun 26, 2026 18:00 JST
MHIET's 500kW-Class Hydrogen Engine Generator Set Achieves Technology Readiness Level for Commercialization
Jun 24, 2026 02:29 JST
DOCOMO Becomes First in Japan to Deploy Nokia's AI-powered MantaRay AutoPilot for Automated Network Optimization
Jun 24, 2026 02:11 JST
Mitsubishi Power and LNGPH Sign Long-Term Deal for Gas Turbine Parts and Services to Advance Energy Resilience in the Philippines
Jun 24, 2026 01:54 JST
Honda to Rename Rugby Team "TOCHIGI Honda HEAT" to Coincide with the Team's New Base of Operation
Jun 24, 2026 00:36 JST
NEC Participates in NATO CCDCOE's Cyber Defense Exercise "Locked Shields 2026"
Jun 24, 2026 00:13 JST
JCB Contactless Expands to Metro de Madrid Enabling Seamless Tap-to-Ride Access Across the Network
Jun 23, 2026 12:00 JST
Fujitsu honored with record-breaking 8 awards at AWS Japan Certification Award 2025, recognized for AI and cloud implementation and talent capabilities
Jun 19, 2026 23:58 JST
Fujitsu spotlights dynamic transformation for business in an AI era as the core theme for the Fujitsu Technology and Service Vision 2026
Jun 19, 2026 23:15 JST
New Heat Dissipation Device Design Achieves a 47% Weight Reduction in an NTN Planar Antenna
Jun 19, 2026 22:39 JST
Hitachi Energy bolsters the regional transformer market with strategic investment in North America
Jun 19, 2026 22:15 JST
Japantastics Introduces Sato Mokko to the World -- A New Chapter in Japanese Artisanal Craftsmanship
Jun 18, 2026 08:00 JST
Hitachi expands its work with OpenAI to accelerate AI-driven modernization and cybersecurity
Jun 17, 2026 14:54 JST
Fujitsu and IBM Japan collaborate on modernization to support enterprise digital transformation
Jun 17, 2026 14:23 JST
Sharp to Introduce AQUOS R11 Smartphone
Jun 17, 2026 13:59 JST
Honda to Begin Supplying Three High-output Models of the eGX Electric Power Unit Series for Commercial-Grade Work Equipment
Jun 17, 2026 13:44 JST
More Latest Release >>
Related Release
Eisai Announces Strategic Investment Supported by the UK Government's LSIMF
6/17/2026 1:28:00 PM JST
Eisai Deepens Body of Clinical Evidence for LENVIMA(R) (Lenvatinib) Across Established Indications at ASCO 2026
5/22/2026 12:23:00 AM JST
Merck & Co., Inc., Rahway, NJ, USA and Eisai Provide Update on Phase 3 LITESPARK-012 Trial Evaluating First-Line Combination Treatments for Certain Patients With Advanced Renal Cell Carcinoma (RCC)
4/21/2026 8:52:00 PM JST
Application Submitted for LENVIMA(R) (lenvatinib) in Japan Seeking Approval of Additional Dosage and Administration for Combination with WELIREG(R) (belzutifan) for Renal Cell Carcinoma that has Progressed After Chemotherapy
3/27/2026 8:14:00 PM JST
Eisai and Nuvation Bio Announce Marketing Authorisation Application for Taletrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer Validated by the European Medicines Agency
3/27/2026 6:19:00 PM JST
Results from Real-World, Long-Term Treatment Persistence with LEQEMBI(R) (lecanemab-irmb) in the United States Presented at AD/PD(TM) 2026
3/23/2026 11:19:00 AM JST
Eisai: Regarding Discontinuation of Administration of "Tazverik(R) Tablets 200mg" (tazemetostat hydrobromide)
3/19/2026 10:54:00 AM JST
Eisai Established the Global Capability Centre in Visakhapatnam, India, to Standardize Global IT Infrastructure Operations and Digital Transformation
3/17/2026 7:49:00 PM JST
Eisai Launches Awareness Campaign on Importance of Sleep Through "Pokemon Sleep" Collaboration
3/12/2026 5:21:00 PM JST
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting
3/11/2026 12:07:00 PM JST
More Press release >>